-
3
-
-
0030942674
-
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with pretreatment prostate specific antigen of >4-20 ng mL
-
D'Amico AV, Whittingon R, Kaplan I. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with pretreatment prostate specific antigen of >4-20 ng mL. Int J Radiat Oncol Biol Phys 1997; 37: 1053-1058.
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.37
, pp. 1053-1058
-
-
D'Amico, A.V.1
Whittingon, R.2
Kaplan, I.3
-
4
-
-
0031781805
-
Dose escalation with 3D conformai treatment: Five year outcomes, treatment optimization, and future directions
-
Hanks GE, Hanlon AL, Schultheiss TE et al. Dose escalation with 3D conformai treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998; 41: 501-510.
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.41
, pp. 501-510
-
-
Hanks, G.E.1
Hanlon, A.L.2
Schultheiss, T.E.3
-
5
-
-
0027722785
-
Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: The role of apoptosis
-
Sklar GN, Eddy HA, Jacobs SC, Kyprianou N. Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis. J Urol 1993; 150: 1526-1532.
-
(1993)
J Urol
, vol.150
, pp. 1526-1532
-
-
Sklar, G.N.1
Eddy, H.A.2
Jacobs, S.C.3
Kyprianou, N.4
-
6
-
-
0029919668
-
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers
-
Krajewska M, Krajewski S, Epstein Ji et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 1996; 148: 1567-1576.
-
(1996)
Am J Pathol
, vol.148
, pp. 1567-1576
-
-
Krajewska, M.1
Krajewski, S.2
Epstein, Ji.3
-
7
-
-
0344406956
-
Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate cardnoma
-
Rosser CJ, Reyes AO, Vakar-Lopez F et al. Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate cardnoma. Int J Radiat Oncol Biol Phys 2003; 56: 1-6.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.56
, pp. 1-6
-
-
Rosser, C.J.1
Reyes, A.O.2
Vakar-Lopez, F.3
-
9
-
-
0021355071
-
Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma and other tissue culture cell lines
-
Tuszynski GP, Cossu G. Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma and other tissue culture cell lines. Cancer Res 1984; 44: 768-771.
-
(1984)
Cancer Res
, vol.44
, pp. 768-771
-
-
Tuszynski, G.P.1
Cossu, G.2
-
10
-
-
33846222824
-
Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways
-
Zhang M, Hongpeng L, Zhenkun T, Griffith BN, Ji M, Li QQ. Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways. Life Sci 2007; 80: 767-774.
-
(2007)
Life Sci
, vol.80
, pp. 767-774
-
-
Zhang, M.1
Hongpeng, L.2
Zhenkun, T.3
Griffith, B.N.4
Ji, M.5
Li, Q.Q.6
-
11
-
-
0038682166
-
Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells
-
Zang M, Liu H, Guo R et al. Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochem Pharmacol 2003; 66: 93-103.
-
(2003)
Biochem Pharmacol
, vol.66
, pp. 93-103
-
-
Zang, M.1
Liu, H.2
Guo, R.3
-
12
-
-
27644461905
-
Non-peptidic small molecule inhibitor of Bcl-2 and Bcl-xL (-)gossypol enhances the biological effect of genistein against BxPC-3 human pancreatic cancer cell line
-
Mohammad RM, Wangs S Banerjee S, et al. Non-peptidic small molecule inhibitor of Bcl-2 and Bcl-xL (-)gossypol enhances the biological effect of genistein against BxPC-3 human pancreatic cancer cell line. Pancreas 2005; 31: 317-324.
-
(2005)
Pancreas
, vol.31
, pp. 317-324
-
-
Mohammad, R.M.1
Wangs, S.2
Banerjee, S.3
-
13
-
-
23144467530
-
Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: Role of wild type p53 and bcl-XL
-
Bauer JA, Trask DK, Kumar B. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild type p53 and bcl-XL. Mol Cancer Ther 2005; 4: 1096-1104.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 1096-1104
-
-
Bauer, J.A.1
Trask, D.K.2
Kumar, B.3
-
14
-
-
34250372159
-
Radiosensitization of tumour cell lines by the polyphenol gossypol results from depressed double-strand break repair and not from enhanced apoptosis
-
Kasten-Pisula U, Windhorst S, Dahm-Daphi J, Mayr G, Dikomey E. Radiosensitization of tumour cell lines by the polyphenol gossypol results from depressed double-strand break repair and not from enhanced apoptosis. Radiother Oncol 2007; 83: 296-303.
-
(2007)
Radiother Oncol
, vol.83
, pp. 296-303
-
-
Kasten-Pisula, U.1
Windhorst, S.2
Dahm-Daphi, J.3
Mayr, G.4
Dikomey, E.5
-
15
-
-
1642478198
-
Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3
-
comment
-
Inayat MS, Chendil D, Mohiuddin M et al. Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3 [comment]. Cancer Biol Ther 2002; 1: 539-545.
-
(2002)
Cancer Biol Ther
, vol.1
, pp. 539-545
-
-
Inayat, M.S.1
Chendil, D.2
Mohiuddin, M.3
-
16
-
-
0029983253
-
Expression of bcl-2 and the progression of human and rodent prostatic cancers
-
Furuya Y, Krajewski S, Epstein JI et al. Expression of bcl-2 and the progression of human and rodent prostatic cancers. Clin Cancer Res 1996; 2: 389-398.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 389-398
-
-
Furuya, Y.1
Krajewski, S.2
Epstein, J.I.3
-
17
-
-
0031930860
-
Indirect radiation leukemogenesis in DBA/2 mice: Increased expression of B2 repeats in FDC-P1 cells transformed by intracistemal A-particle transposition
-
Blumenstein M, Hossfeld DK, Duhrsen U. Indirect radiation leukemogenesis in DBA/2 mice: increased expression of B2 repeats in FDC-P1 cells transformed by intracistemal A-particle transposition. Ann Hematol 1998; 76: 53-60.
-
(1998)
Ann Hematol
, vol.76
, pp. 53-60
-
-
Blumenstein, M.1
Hossfeld, D.K.2
Duhrsen, U.3
-
18
-
-
0022600015
-
Tumor-host interactions as prognostic factors in the histologic assessments of carcinomas
-
Crissman JD. Tumor-host interactions as prognostic factors in the histologic assessments of carcinomas. Pathol Annu 1986; 1: 29-52.
-
(1986)
Pathol Annu
, vol.1
, pp. 29-52
-
-
Crissman, J.D.1
-
19
-
-
0036285604
-
Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer
-
Gleave ME, Zellweger T, Chi K et al. Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer. Invest New Drugs 2002; 20: 145-158.
-
(2002)
Invest New Drugs
, vol.20
, pp. 145-158
-
-
Gleave, M.E.1
Zellweger, T.2
Chi, K.3
-
20
-
-
0029739758
-
Radiation inactivation of human prostate cancer cells: The role of apoptosis
-
Algan O, Stobbe CC, Helt AM et al. Radiation inactivation of human prostate cancer cells: the role of apoptosis. Radiat Res 1996; 146: 267-275.
-
(1996)
Radiat Res
, vol.146
, pp. 267-275
-
-
Algan, O.1
Stobbe, C.C.2
Helt, A.M.3
-
21
-
-
27744431949
-
Investigation on gossypol: Past and present developments
-
Kalliopi D. Investigation on gossypol: past and present developments. Expert Opin Investig Drugs 2005; 14: 1419-1434.
-
(2005)
Expert Opin Investig Drugs
, vol.14
, pp. 1419-1434
-
-
Kalliopi, D.1
-
22
-
-
64049109575
-
Profiling of angiogenic cytokines produced by hormone-and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol
-
Karaca B, Kucukzeybek Y, Gurumlu G et al. Profiling of angiogenic cytokines produced by hormone-and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol. Eur Cytokine Netw 2008; 19: 176-184.
-
(2008)
Eur Cytokine Netw
, vol.19
, pp. 176-184
-
-
Karaca, B.1
Kucukzeybek, Y.2
Gurumlu, G.3
-
23
-
-
20044368078
-
Gossypol enhances response to radiation therapy and results in tumour regression of human prostate cancer
-
Xu L, Yang D, Wang S et al.Gossypol enhances response to radiation therapy and results in tumour regression of human prostate cancer. Mol Cancer Ther 2005; 4: 197-205.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 197-205
-
-
Xu, L.1
Yang, D.2
Wang, S.3
-
24
-
-
13944262237
-
Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance
-
Oliver CL, Miranda MB, Shangary S. Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance. Mol Cancer Ther 2005; 4: 25-30.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 25-30
-
-
Oliver, C.L.1
Miranda, M.B.2
Shangary, S.3
-
25
-
-
13944252626
-
Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma
-
Mohammad RM, Wang S, Aboukameel A et al. Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma. Mol Cancer Ther 2005; 4: 13-21.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 13-21
-
-
Mohammad, R.M.1
Wang, S.2
Aboukameel, A.3
|